These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16816225)

  • 1. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
    Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
    Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Barburoğlu M
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):219-26. PubMed ID: 25256264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
    Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
    Sumitani S; Harada M; Kubo H; Ohmori T
    Psychiatry Res; 2007 Jan; 154(1):85-92. PubMed ID: 17208418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment.
    Lázaro L; Bargalló N; Andrés S; Falcón C; Morer A; Junqué C; Castro-Fornieles J
    Psychiatry Res; 2012 Jan; 201(1):17-24. PubMed ID: 22281202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive-compulsive disorder.
    Moon CM; Jeong GW
    J Affect Disord; 2018 Feb; 227():603-612. PubMed ID: 29172053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-Tesla.
    Kitamura H; Shioiri T; Kimura T; Ohkubo M; Nakada T; Someya T
    Acta Psychiatr Scand; 2006 Aug; 114(2):101-8. PubMed ID: 16836597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Wang Y; Jia Y; Xu G; Ling X; Liu S; Huang L
    J Affect Disord; 2012 Feb; 136(3):620-6. PubMed ID: 22129769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
    O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
    J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.
    Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions.
    Besiroglu L; Sozen M; Ozbebit O; Avcu S; Selvi Y; Bora A; Atli A; Unal O; Bulut MD
    Acta Psychiatr Scand; 2011 Aug; 124(2):141-51. PubMed ID: 21627621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.
    Yücel M; Harrison BJ; Wood SJ; Fornito A; Wellard RM; Pujol J; Clarke K; Phillips ML; Kyrios M; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2007 Aug; 64(8):946-55. PubMed ID: 17679639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing brain magnetic resonance spectroscopy findings of pediatric treatment-naive obsessive-compulsive disorder patients with healthy controls.
    Yalçın O; Sener S; Konuş Boyunağa OL; Sarıpınar EG; Oğur T; Güney E; Akın Sarı B; Işeri E
    Turk Psikiyatri Derg; 2011; 22(4):222-9. PubMed ID: 22143947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
    Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
    Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
    Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
    BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter abnormalities in drug-naïve patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment.
    Yoo SY; Jang JH; Shin YW; Kim DJ; Park HJ; Moon WJ; Chung EC; Lee JM; Kim IY; Kim SI; Kwon JS
    Acta Psychiatr Scand; 2007 Sep; 116(3):211-9. PubMed ID: 17655563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.